Form 4: Hims & Hers Health Chief Legal Officer Soleil Boughton Reports Stock Transactions
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the vesting and disposal of restricted stock units (RSUs) to cover tax obligations.
Summary
- On March 15, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., reported transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
- Boughton acquired 33,232 shares of Class A Common Stock through the vesting of RSUs.
- 18,208 shares were disposed of to cover tax withholding obligations at a price of $14.63 per share.
- Following these transactions, Boughton directly owns 169,369 shares of Class A Common Stock.
- The transactions also involved the vesting of various tranches of RSUs granted in previous years (2020, 2021, 2022, and 2023).
- After the reported transactions, Boughton continues to hold a significant number of RSUs.
Sentiment
Score: 5
Explanation: This Form 4 filing is a routine disclosure of insider transactions. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into executive compensation and stock ownership.
Positives
- The vesting of RSUs indicates that Boughton is meeting the service-based requirements of her equity grants.
Negatives
- The disposal of shares to cover tax obligations reduces Boughton's direct ownership of Hims & Hers Health stock.
Risks
- Future vesting events and subsequent sales of shares could potentially dilute existing shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in the financial industry.
- Comparing the volume and frequency of insider transactions at Hims & Hers Health to those of its peers (e.g., Teladoc Health, GoodRx) can provide insights into the relative health and prospects of the company.
- Analyzing the ratio of stock options to actual stock ownership among Hims & Hers Health executives compared to industry benchmarks can reveal potential misalignment of incentives.
Stakeholder Impact
- The transactions have a minor impact on shareholders through potential dilution from the vesting of RSUs.
- Employees holding RSUs are positively impacted as they vest and convert into shares.
Key Dates
| Date | Description |
|---|---|
| 03/15/2020 | Earliest date of RSUs vesting in quarterly installments. |
| 03/15/2021 | Earliest date of RSUs vesting in quarterly installments. |
| 06/15/2022 | Earliest date of RSUs vesting in quarterly installments. |
| 06/15/2023 | Earliest date of RSUs vesting in quarterly installments. |
| 03/15/2024 | Date of the reported transactions (vesting and disposal of shares). |
| 03/19/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.